You Have a Great Story
WE KNOW HOW TO TELL IT
Bioscribe was founded in 1997 in the San Francisco Bay Area to support the area's growing biotechnology industry. For nearly 20 years, we have been a leading boutique PR agency working with companies that powered the Human Genome Project and cutting-edge start-ups that are innovating to unlock its value. We've helped launch first, second and third-generation DNA sequencing systems, gene expression tools, bioinformatics software, single cell analysis solutions, molecular diagnostics, DNA forensics systems, next-generation therapies, and vaccines.
Our senior PR consultants and writers, each with 15+ years of experience, bring decades of experience and expertise in the biotech, molecular diagnostics, pharma, and life science research markets. In addition to previous large PR agency experience, some of our team members have built and run in-house communications teams, and have covered the industry as journalists and editors of leading publications.
If you need help telling your great stories, we'd love to talk to you. Contact us at
info [@] bioscribe.com.
AREAS OF EXPERTISE
We help our clients define their messaging and positioning, identify publicity opportunities, manage day-to-day corporate and product news flow, and get media coverage.
Areas of expertise include:
To submit RFPs, or to learn more about what we do, please contact us at info [@] bioscribe.com.
Media Strategy & Relations
Positioning & Messaging, Media Audits, Media Lists, Editorial Calendars, Journalist Outreach, Interview Preparation & Facilitation, Media Training, Coverage Monitoring
Editorial Strategy & Content Marketing
Editorial Planning, Customer Profiles, Content Development & Editing, Bylined Articles, White Papers, Case Studies, Marketing Collateral, Social Media & Website Content
Messaging & Positioning, Publicity Plans, Press Releases, News Distribution, Media Events, Product Placement, Tradeshow Support
Blog & Newsletter Content
Editorial Calendar Planning, Content Development, Managing Approval Process
Thought Leadership & Industry Recognition
Presentation/Talk Development, Op-Eds, Speaking Opportunities, Awards Programs
Corporate Positioning & Branding, Financing Milestones, Mergers & Expansions, Organizational Communicatons, Issues Management
It's The Companies We Keep
Our clients include innovative start-ups powering the DNA revolution, therapeutics companies with the next potential breakthrough for cancer, innovative life science technology companies expanding markets, and financiers of healthcare innovation.
Developing therapeutic antibodies for inflammatory and proliferative diseases
San Carlos, CA
Allakos is a clinical-stage company developing antibodies that target receptor molecules present on the surface of immune effector cells involved in allergy, inflammation and tissue damage.
Intercepting cancer's survival mechanisms
Aravive is developing novel cancer therapeutics that spare healthy cells while targeting tumor adaptive responses and cancer evasion pathways. The company's primary therapeutics focus is the GAS6-AXL pathway, whereby they can interrupt oncogenic signals and turn off the "survival switch" that allows cancer to grow, spread, and acquire therapeutic resistance.
Actionable strategies for life sciences
Bionest works to create competitive advantage for its clients by developing innovative and differentiated strategies at the corporate, portfolio and brand levels of medical and life science businesses. They also provide valuation and due diligence services to companies, investors and private equity.
Cancer diagnostics company with unique liquid biopsy technology for better monitoring of disease progression
Westlake Village, CA
Cynvenio is a commercial-stage clinical diagnostics company that leverages its proprietary LiquidBiopsy® multi-template technology for the molecular characterization of tumor cells from a standard blood draw.
Leading the next generation of DNA synthesis
Eurofins Genomics company is an international provider of DNA sequencing services, genotyping services, DNA synthesis products, and bioinformatics services for pharma, diagnostics, food, agriculture, biotechnological, and research markets. Eurofins Genomics operates leading R&D and production sites in the USA, Canada, Germany, India, and Japan. Eurofins Genomics is the genomic services brand of the Eurofins Group, the worldwide leader in food, environmental and pharmaceutical testing.
The future of science is sound
Labcyte is revolutionizing liquid handling. Its Echo liquid handling systems use sound to precisely transfer liquids without contact, eliminating the use of pipettes. Labcyte instruments are used worldwide throughout the pharmaceutical industry, diagnostic companies, genome centers, genomic service companies, biotechnology firms, contract research organizations, and academic institutions.
Breakthrough solutions to improve health and advance science
Luminex aims to transform global healthcare and life science research through the development, manufacturing, and marketing of proprietary instruments and assays that deliver cost-effective, rapid results to clinicians and researchers.
Harnessing the microbiome to improve health
Mountain View, CA
Osel, Inc. is pioneering a new class of medicine called Live Biotherapeutic Products (LBPs) that modulate the body’s natural microbiome to restore health and prevent infection. In 2003, Osel was one of the first companies to receive FDA authorization to test a live bacterial therapeutic, and is a pioneer in the field of LBPs. Women's health is their unique focus.
Investment bankers for middle market growth companies in life sciences
Wellesley, Mass and Reston, VA
Outcome Capital is a unique investment banking firm that provides middle-market growth companies in the life sciences, healthcare services and technology markets with a value-added client-centric approach to merger, acquisition and corporate finance advisory services.
Third-generation DNA sequencing for complex genomics projects
Menlo Park, CA
Pacific Biosciences in transforming the way humankind acquires, processes and interprets data from living systems through the design, development and commercialization of innovative tools for biological research.
The global leader in applications to quickly analyze and interpret genomic data
Redwood City, CA
Ingenuity Systems is a leading provider of biomedical information and analysis solutions for the exploration, interpretation and analysis of complex biological systems.
DNA size selection for next-gen sequencing
Sage Science develops products for sale to the Life Sciences research and Diagnostic laboratory markets. The company's mission is to provide new systems to streamline and improve sample preparation workflows.
Developers of hand-held, battery operated molecular detection systems
Santa Cruz, CA
Two Pore Guys (2PG) develops single-molecule sensing technologies that employ solid-state nanopores and biochemical reagents to create a versatile sample-in/results-out detection platform. 2PG’s first product is a handheld device that can use reagents from existing molecular or analyte diagnostic assays and provide accuracy and sensitivity rivaling sophisticated laboratory equipment.
Replicating physiologically relevant conditions for cell-based assays
San Francisco, CA
Xcell is developing revolutionary products and workflows for life science and translational research that reproduce physiologically relevant conditions to enable more meaningful, biologically relevant experiments. The company’s tools empower scientists to obtain accurate and actionable results in important fields such as cancer research, biomarker discovery, lead candidate selection and optimization, stem cell research and regenerative medicine, and immunotherapy drug development.
Some of our past clients include:
Association for Molecular Pathology, Applied Biosystems, BD Biosciences, Benchling, Biotique Systems, Cellular Resarch (purchased by BD) Chiron Corporation, Connetics Corporation, DNAnexus, DoubleTwist, Eos, GE healthymagination, Gen9, Genentech, GenoSpectra, IntegenX, Invitrogen, Microsoft Health Solutions, Medtronic, Mohr Davidow Ventures, NanoString Technologies, Nektar, NIST: Multiplexed Biomolecular Science Group, Omicia, PAG, PaxVax, Personalis, RainDance Technologies, StationX, Varian Medical Systems, VitaPath Genetics, Zyomyx
President & CEO
Nicole founded Bioscribe in 1997 in San Francisco to meet the communications needs of the emerging biotech industry. She has more than 20 years experience providing PR counsel to Fortune 500 companies, small start-ups, and non-profit associations in this industry.
Vice President, Editorial Strategy
OUR CLIENTS IN THE NEWS
Here is a sample of some of the stories we are helping to tell...
AAAS Press Kit
Here you will find additional information for clients participating in the AAAS media breakfast Next-Generation Life Science Technologies: How Silicon Valley is Revolutionizing Biomedical and AgBio Research
We are a small group of senior, self-directed professionals passionate about helping clients communicate stories about life science innovations. We are currently recruiting PR counselors, media relations pros, and scientific marketing content writers and MarCom experts who have experience working on biotech accounts. Please send a copy of your resume to us (info [at] bioscribe [dot] com). If it looks like a great match, we'll be in touch. Thanks!